advanced-cancer

Documents about advanced-cancer

• Safety Study of Whole Body Hyperthermia for Advanced Cancer#303717ClinicalTrials.gov
• AIMS Cancer Outcomes Study#130988ClinicalTrials.gov
• Clinical Study of Granulocyte Infusion for Advanced Cancer#329538ClinicalTrials.gov
• Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC#303752ClinicalTrials.gov
• Oral Administration of STC-15 in Subjects With Advanced Malignancies#444867ClinicalTrials.gov
• Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer#369829ClinicalTrials.gov
• CAR-T Cell Immunotherapy for Advanced Lung Cancer#474763ClinicalTrials.gov
• RC48-ADC in HER2-low Advanced Breast Cancer#804756ClinicalTrials.gov
• Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer#311139ClinicalTrials.gov
• Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer#172310ClinicalTrials.gov
• Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer#261505ClinicalTrials.gov
• Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer#160232ClinicalTrials.gov
• Plasmodium Immunotherapy for Advanced Ovarian Cancer#633729ClinicalTrials.gov
• Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer#633759ClinicalTrials.gov
• Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV#426781ClinicalTrials.gov
• Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer#217041ClinicalTrials.gov
• FS222 First in Human Study in Patients With Advanced Malignancies#217016ClinicalTrials.gov
• Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer#152397ClinicalTrials.gov
• Plasmodium Immunotherapy for Breast and Liver Cancers#253014ClinicalTrials.gov
• Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer#366607ClinicalTrials.gov
• Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer#363615ClinicalTrials.gov
• A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers#307324ClinicalTrials.gov
• Dostarlimab and Cobolimab in Advanced Cervical Cancer#467575ClinicalTrials.gov
• Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer.#123458ClinicalTrials.gov
• Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas#158228ClinicalTrials.gov
• Neoadjuvant Short-course Radiotherapy Followed by the Combination of Immunotherapy and Chemotherapy in Locally Advanced Rectal Cancer#651255ClinicalTrials.gov
• Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer#349973ClinicalTrials.gov
• First-Line and Neoadjuvant Immunotherapy for Gastric Cancer#432880ClinicalTrials.gov
• Predictive Value of Exosomes in Pleural Effusion for Advanced Lung Cancer#432894ClinicalTrials.gov
• PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer#127572ClinicalTrials.gov
• Vigil™ + Nivolumab in Advanced Non-Small Cell Lung Cancer#311135ClinicalTrials.gov
• TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation#414498ClinicalTrials.gov
• NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours#300256ClinicalTrials.gov
• Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer#387169ClinicalTrials.gov
• Advanced Cervical Cancer Trial in India#125845ClinicalTrials.gov
• Evaluating Disparities in Precision Oncology#623566ClinicalTrials.gov
• Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer#143549ClinicalTrials.gov
• Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors#201777ClinicalTrials.gov
• Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer#283054ClinicalTrials.gov
• Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer#329537ClinicalTrials.gov
• Clinical Study of MSH2-/- Tumor Cell Vaccines for Advanced pMMR Colorectal Cancer Patients#451526ClinicalTrials.gov
• Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors#366597ClinicalTrials.gov
• VSV-02 Compassionate Use in Advanced Solid Tumors#230415ClinicalTrials.gov
• Metronomic Oral Paclitaxel Monotherapy and Combined Immunotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose Exploration and Expansion Trial#417553ClinicalTrials.gov
• Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC#314317ClinicalTrials.gov
• The Efficacy and Safety of ARNI on the Outcome of Advanced Lung Cancer With Concurrent Hypertension#417461ClinicalTrials.gov
• Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors#201781ClinicalTrials.gov
• Serplulimab for Locally Advanced Cervical Cancer#287521ClinicalTrials.gov
• STRIDE - STimulating Immune Response In aDvanced brEast Cancer#143670ClinicalTrials.gov
• Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer#174865ClinicalTrials.gov